140 related articles for article (PubMed ID: 23677397)
1. Identification of integrin β1 as a prognostic biomarker for human lung adenocarcinoma using 2D-LC-MS/MS combined with iTRAQ technology.
Zhang PF; Zeng GQ; Yi LZ; Liu JP; Wan XX; Qu JQ; Li JH; Li C; Tang CE; Hu R; Ye X; Chen Y; Chen ZC; Xiao ZQ
Oncol Rep; 2013 Jul; 30(1):341-9. PubMed ID: 23677397
[TBL] [Abstract][Full Text] [Related]
2. Identification of flotillin-1 as a novel biomarker for lymph node metastasis and prognosis of lung adenocarcinoma by quantitative plasma membrane proteome analysis.
Zhang PF; Zeng GQ; Hu R; Li C; Yi H; Li MY; Li XH; Qu JQ; Wan XX; He QY; Li JH; Chen Y; Ye X; Li JY; Wang YY; Feng XP; Xiao ZQ
J Proteomics; 2012 Dec; 77():202-14. PubMed ID: 22982323
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of annexin II expression in non-small cell lung cancer.
Luo CH; Liu QQ; Zhang PF; Li MY; Chen ZC; Liu YF
Clin Transl Oncol; 2013 Nov; 15(11):938-46. PubMed ID: 23529818
[TBL] [Abstract][Full Text] [Related]
5. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
[TBL] [Abstract][Full Text] [Related]
6. Identification and Characterization of Potential Biomarkers by Quantitative Tissue Proteomics of Primary Lung Adenocarcinoma.
Hsu CH; Hsu CW; Hsueh C; Wang CL; Wu YC; Wu CC; Liu CC; Yu JS; Chang YS; Yu CJ
Mol Cell Proteomics; 2016 Jul; 15(7):2396-410. PubMed ID: 27161446
[TBL] [Abstract][Full Text] [Related]
7. Identification of annexin A1 as a proinvasive and prognostic factor for lung adenocarcinoma.
Liu YF; Zhang PF; Li MY; Li QQ; Chen ZC
Clin Exp Metastasis; 2011 Jun; 28(5):413-25. PubMed ID: 21365324
[TBL] [Abstract][Full Text] [Related]
8. Exploration of differentially expressed plasma proteins in patients with lung adenocarcinoma using iTRAQ-coupled 2D LC-MS/MS.
Li W; Zheng H; Qin H; Liu G; Ke L; Li Y; Li N; Zhong X
Clin Respir J; 2018 Jun; 12(6):2036-2045. PubMed ID: 29363881
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between expression of long non-coding RNA ZXF1 and prognosis of lung adenocarcinoma and its potential molecular mechanism].
Pan GF; Zhou XF; Zhao JP
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):102-108. PubMed ID: 28219204
[No Abstract] [Full Text] [Related]
10. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
11. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of survivin, cyclin D1, integrin beta1, and VEGF in patients with small adenocarcinoma of stage I lung cancer.
Oshita F; Ito H; Ikehara M; Ohgane N; Hamanaka N; Nakayama H; Saito H; Yamada K; Noda K; Mitsuda A; Kameda Y
Am J Clin Oncol; 2004 Aug; 27(4):425-8. PubMed ID: 15289739
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomic analysis identifying three annexins as lymph node metastasis-related proteins in lung adenocarcinoma.
Liu YF; Chen YH; Li MY; Zhang PF; Peng F; Li GQ; Xiao ZQ; Chen ZC
Med Oncol; 2012 Mar; 29(1):174-84. PubMed ID: 21132403
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of caveolin-1 expression with clinicopathologic features and prognosis in patients with lung adenocarcinoma].
Wang Y; Liu B; Xu Y; Zhang J; Xia Q; Yu B; Zhang R; Shi S; Lu Z; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):251-5. PubMed ID: 24915816
[TBL] [Abstract][Full Text] [Related]
15. High expression of integrin beta1 and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer.
Oshita F; Kameda Y; Hamanaka N; Saito H; Yamada K; Noda K; Mitsuda A
Am J Clin Oncol; 2004 Jun; 27(3):215-9. PubMed ID: 15170136
[TBL] [Abstract][Full Text] [Related]
16. The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment.
Ma Y; Fan M; Dai L; Kang X; Liu Y; Sun Y; Yan W; Liang Z; Xiong H; Chen K
Tumour Biol; 2015 Sep; 36(10):8085-92. PubMed ID: 25982999
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
[TBL] [Abstract][Full Text] [Related]
19. Increased AAA-TOB3 correlates with lymph node metastasis and advanced stage of lung adenocarcinoma.
Liu Y; Bu L; Li W; Wu W; Wang S; Diao X; Zhou J; Chen G; Yang S
Int J Biol Markers; 2017 Jul; 32(3):e325-e332. PubMed ID: 28623644
[TBL] [Abstract][Full Text] [Related]
20. TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells.
Li Z; Jiang X; Zhang W
Biochem Biophys Res Commun; 2016 Jan; 470(1):197-204. PubMed ID: 26773504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
